The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.80BCNY
300.43M · vs all stocks (USD)
Updated Nov 22, 2026
Revenue (TTM)
968.79MCNY
129.64M · vs all stocks (USD)
Updated Nov 22, 2026
Profit Margin
-18.00%
vs Medical Devices peers
Updated Nov 22, 2026
Beta
0.2600x
vs all stocks
Updated Nov 22, 2026
52-Week Change
-50.93%
vs all stocks
Updated Nov 22, 2026
Market Capitalization
1.80BCNY
300.43M · vs all stocks (USD)
Updated Nov 22, 2026
Enterprise Value
1.75BCNY
290.64M · vs all stocks (USD)
Updated Nov 22, 2026
Forward P/E
3.06x
vs Medical Devices peers
Updated Nov 22, 2026
Price to Sales (TTM)
1.86x
vs Medical Devices peers
Updated Nov 22, 2026
Price to Book (MRQ)
1.19x
vs Medical Devices peers
Updated Nov 22, 2026
Enterprise to Revenue
1.81x
vs Medical Devices peers
Updated Nov 22, 2026
Enterprise to EBITDA
-14.82x
vs Medical Devices peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 104.72×.Updated Nov 22, 2026
Gross Margin
45.95%
vs Medical Devices peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 27.36%.Updated Nov 22, 2026
Profit Margin
-18.00%
vs Medical Devices peers
Updated Nov 22, 2026
Operating Margin
-16.48%
vs Medical Devices peers
Updated Nov 22, 2026
Return on Assets (TTM)
-3.80%
vs Medical Devices peers
Updated Nov 22, 2026
Return on Equity (TTM)
-10.21%
vs Medical Devices peers
Updated Nov 22, 2026
Revenue (TTM)
968.79MCNY
129.64M · vs all stocks (USD)
Updated Nov 22, 2026
Revenue per Share (TTM)
3.54CNYUpdated Nov 22, 2026
Quarterly Revenue Growth
88.00%
vs Medical Devices peers
Updated Nov 22, 2026
Gross Profit (TTM)
265.10MCNY
26.18M · vs all stocks (USD)
Updated Nov 22, 2026
EBITDA (TTM)
16.72MCNY
2.51M · vs all stocks (USD)
Updated Nov 22, 2026
Net Income (TTM)
-174.35MCNY
-31.49M · vs all stocks (USD)
Updated Nov 22, 2026
Quarterly Earnings Growth (YoY)
26.49%
vs Medical Devices peers
Updated Nov 22, 2026
Operating Cash Flow (TTM)
-30.44MCNY
-9.94M · vs all stocks (USD)
Updated Nov 22, 2026
5-Year Average Dividend Yield
2.08%
vs all stocks
Updated Nov 22, 2026
Payout Ratio
208.33%
vs Medical Devices peers
Updated Nov 22, 2026
Minority Interest (Equity)
4.07KCNYFY2025 · Dec 31, 2025
Revenue
807.06MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
479.61MCNYFY2025 · Dec 31, 2025
Gross Profit
327.45MCNYFY2025 · Dec 31, 2025
Operating Income
-87.40MCNY
-13.10M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-298.40MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-52.40MCNYFY2025 · Dec 31, 2025
Net Income
-246.00MCNYFY2025 · Dec 31, 2025
EBIT
-265.44MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
16.72MCNYFY2025 · Dec 31, 2025
Research & Development
121.76MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
95.60MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
11.02MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
31.60MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
32.96MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.9000CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.9000CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
273.32MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
273.32MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-246.00MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
9.06KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
35.57MCNYFY2025 · Dec 31, 2025
Free Cash Flow
13.08MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
308.01MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-246.00MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
20.81MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
138.00MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
122.76MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-22.50MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-676.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
517.53MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-180.97MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
425.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-475.60MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-81.98MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-4.46MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-137.04MCNYFY2025 · Dec 31, 2025
Shares Outstanding
272.70MSharesUpdated Nov 22, 2026
Float Shares
130.33MSharesUpdated Nov 22, 2026
% Held by Insiders
25.95%
vs all stocks
Updated Nov 22, 2026
% Held by Institutions
28.34%
vs all stocks
Updated Nov 22, 2026
Total Cash (MRQ)
519.88MCNY
80.42M · vs all stocks (USD)
Updated Nov 22, 2026
Total Cash per Share (MRQ)
1.91CNYUpdated Nov 22, 2026
Total Debt (MRQ)
468.24MCNY
70.63M · vs all stocks (USD)
Updated Nov 22, 2026
Total Debt to Equity (MRQ)
0.3079x
vs Medical Devices peers
Updated Nov 22, 2026
Current Ratio (MRQ)
1.80x
vs Medical Devices peers
Updated Nov 22, 2026
Book Value per Share (MRQ)
5.58CNYUpdated Nov 22, 2026
Total Assets
2.77BCNY
415.51M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.72BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.24BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.05BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
280.96MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
954.27MCNYFY2025 · Dec 31, 2025
Cash
308.01MCNYFY2025 · Dec 31, 2025
Cash Equivalents
1.58MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
309.59MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
180.32MCNYFY2025 · Dec 31, 2025
Accounts Receivable
195.69MCNYFY2025 · Dec 31, 2025
Inventory
568.01MCNYFY2025 · Dec 31, 2025
Accounts Payable
167.25MCNYFY2025 · Dec 31, 2025
Short-term Debt
205.70MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
49.79MCNYFY2025 · Dec 31, 2025
Long-term Debt
245.30MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
272.70MCNYFY2025 · Dec 31, 2025
Retained Earnings
844.90MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.54BCNY
230.36M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
5.96CNYUpdated Nov 22, 2026
52-Week High
14.12CNYUpdated Nov 22, 2026
52-Week Change
-50.93%
vs all stocks
Updated Nov 22, 2026
Beta
0.2600x
vs all stocks
Updated Nov 22, 2026
50-Day MA
7.12CNYUpdated Nov 22, 2026
200-Day MA
8.59CNYUpdated Nov 22, 2026
Avg 10-Day Volume
1.83MSharesUpdated Nov 22, 2026
Avg 30-Day Volume
2.36MSharesUpdated Nov 22, 2026
Diluted EPS (TTM)
-0.6400CNYUpdated Nov 22, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable